Results 11 to 20 of about 41,043 (214)

Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients [PDF]

BMC Medicine, 2022
Background In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated (CoronaVac) and mRNA (BNT162b2) COVID-19 vaccines using a population-based
Carlos King Ho Wong, David Tak Wai Lui, Xi Xiong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Ching Lung Cheung, Chi Ho Lee, Yu Cho Woo, Ivan Chi Ho Au, Matthew Shing Hin Chung, Franco Wing Tak Cheng, Kathryn Choon Beng Tan, Ian Chi Kei Wong   +14 more
doaj   +2 more sources

Effectiveness of a third dose of COVID-19 vaccines against delta variant of SARS-COV-2: A Serbian cohort study [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2023
Introduction/Objective. The duration of vaccine-induced protection against SARS-CoV-2 is shown to be limited. The aim of this study was to assess vaccine effectiveness (VE) of a third dose of four different COVID-19 vaccines during Delta variant ...
Đorđević Nataša, Matić Sanja, Milovanović Dragan, Stefanović Srđan, Popović Suzana, Todorović Danijela, Đurđević Predrag, Sazdanović Predrag, Antić Vasilije, Lončar Slavica, Bukumira Slavica, Radenković Marko, Šusteršić Tijana, Filipović Nenad, Baskić Dejan   +14 more
doaj   +1 more source

Beyond neutralization for BNT162b2 mRNA vaccination [PDF]

Cell Host & Microbe, 2021
Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2.
Damani-Yokota, Payal, Yeung, Stephen T., Khanna, Kamal M.   +2 more
openaire   +2 more sources

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial [PDF]

, 2022
BACKGROUND: Some high-income countries have deployed fourth doses of COVID-19 vaccines, but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain.
Abeywickrama, Movin, Adams, Kirsty, Ahmed, Nabeela Nazir, Aley, Parvinder K, Aley, Parvinder K, Allen, Lauren, Alves, Carlota Pereira Dias, Ambihapathy, Wythehi, Andrews, Antonette, Andrews, Nick, Andrews, Nick, Appleby, Kim, Askoolam, Krishna, Aslam, Suahil, Babbage, Gavin, Babbage, Gavin, Baker, Helena, Baker, Holly, Baker, Jonathan, Baker, Natalie, Barcella, Lara, Barker, Dominique, Barry, Joshua, Baryschpolec, Sonia, Batham, Sally, Bawa, Tanveer, Bawa, Tanveer, Baxter, David, Baxter, David, Beckett, Helen, Bell, Judith, Bennett, Sara, Bentley, Ian, Berry, Lisa, Bibi, Sagida, Bisnauthsing, Karen, Bonnaud, Avril, Borca, Alessandro, Boubriak, Iryna, Bousfield, Rachel, Brandon, Jacqueline, Branney, Debbie, Broadhead, Samantha, Brown, Claire, Brown, Phillip, Brunt, Emily, Buadi, Amanda, Bula, Marcin, Bula, Marcin, Burton, Holly, Burton, Katharine, Buttigieg, Karen, Calderwood, James, Campbell, Marion, Cathie, Katrina, Cathie, Katrina, Chalwin, Olivia, Champaneri, Trishna, Charlton, Sue, Charlton, Sue, Chatterjee, Krishna, Chatterjee, Krishna, Chiplin, Emily, Choi, Bea, Clutterbuck, Elizabeth A, Cole, Christine, Colquhoun, Suzie, Cooper, Alison, Cooper, Chris, Cornelius, Victoria, Cornelius, Victoria, Corrah, Tumena, Coughlan, Tricia, Cox, Stephen, Cullinane, James, Cutts, Rebecca, Dare, Tracey, Davies, Ceri, Davies-Dear, Sharon, DeLosSantosDominguez, Pamela, Desai, Amisha, Dineen, Emily, Dodd, Kate, Dodd, Kate, Domingo, Jason, Drake-Brockman, Rachael, Driver, Kimberley, Edwards, Christopher J, Egbo, Akamino, Elliott, Ryan Stephen, Elliott, Scott, Ellis, Kate, Enever, Yvanne, Enever, Yvanne, Evans, Julie, Farooqi, Sadaf, Farrier, Adam, Faust, Saul N, Faust, Saul N, Feng, Shuo, Feng, Shuo, Fowler, Simon, Fox, Lauren, Frankham, Jorden, Fraser, Sara, Freedman, Andrew, Galvin, Dominic, Gardside, Ben, Garrahy, Sarah, Gavin, John, Gibney, Jennifer, Giddins, Beth, Godwin, Kerry, Gokani, Karishma, Goncalvescordeiro, Lillian, Goodman, Anna L, Goodman, Anna L, Gordon, Elizabeth, Gouriet, Jade, Gowland, Andrew, Graham, Victoria, Green, Christopher A, Green, Christopher A, Grierson, Jacques, Grundy, Lynne, Gutteridge, Helen, Habash-Bailey, Haniah, Hailstone, Jessica, Hale, Colin, Hall, Fran, Hall, Jane, Hallis, Bassam, Hallis, Bassam, Hamal, Shama, Hansen, Daniel, Hardy, Anna, Harndahl, Linda, Harndahl, Linda, Harrison, Elizabeth, Haskell, Louise, Haughney, John, Haughney, John, Haydock, Helen, Haye, Anastasia de la, Herbert, Christopher, Hicks, Alexander, Hicks, Alexander, Hladkiwskyj, John, Hogan, Alison, Holliday, Kyra, Holliday, Kyra, Honey, Thomas, Horsfall, Emily, Hughes, Kerry, Hughes, Rachel, Hurdover, Steve, Irwin, Margaret, James, Rob, Janani, Leila, Janani, Leila, John, Laurence, Jones, Lona Tudor, Justice, Edwin, Kamal, Mohammed, Kanji, Nasir, Kanji, Nasir, Kasanyinga, Mwila, Katechia, Kashyap, Keenan, Samantha, Khan, Mohammed, King, Mikayala, Klaauw, Agatha A van der, Klaauw, Agatha A van der, Knight, Chanice, Kourampa, Evgenia, Kownacka, Alicia, Kumar, Dileep, Ladikou, Eleni, Lakeman, Nicki, Lall, Paminder, Lambe, Teresa, Lambe, Teresa, Lee, Kim, Leung, Stephanie, Lewis-Taylor, Jessica, Li, Grace, Libri, Vincenzo, Libri, Vincenzo, Lingwood, Aidan, Littlewood, Kelly, Liu, Xinxue, Liu, Xinxue, Llewelyn, Martin J, Llewelyn, Martin J, Locke, Emily, Longhurst, Beverley, Lyon, Rebecca, Maallah, Mina, Maallah, Mina, Macdonald, Jonathan, Magan, Javier, Magee, Alan, Males, Samantha, Mallon, Lewis, Mansfield, Becky, Marius, Phedra, McDonnell, Chloe, McGreevy, Caitlin, McGregor, Alastair C, McGregor, Alastair C, McMillan, Gillian, Merida-Morillas, Marta, Minassian, Angela M, Minassian, Angela M, Minnis, Christine, Moon, Maria, Moorbey, Chantelle, Moore, Patrick, Moore, Patrick, Moore, Sophie, Morshead, Gertraud, Mouland, Johanna, Mpelembue, Mushiya, Mughal, Mehmood, Mughal, Mehmood, Mujadidi, Yama F, Mujadidi, Yama F, Mullan, Dee, Munro, Alasdair P S, Munro, Alasdair P S, Munusamy, Malathi, Murira, Jennifer, Nabunjo, Martha, Naker, Kush, Newman, Joseph, Nguyen-Van-Tam, Jonathan S, Nguyen-Van-Tam, Jonathan S, Nightingale, Kari, Oliver, Abigail, Osanlou, Orod, Osanlou, Orod, Osanlou, Rostam, Osanlou, Rostam, Osuji, Carol, Owens, Daniel R, Owens, Daniel R, Packham, Alice, Pacurar, Mihaela, Pacurar, Mihaela, Palfreeman, Adrian, Palfreeman, Adrian, Palmer, Emily, Pan, Daniel, Pan, Daniel, Parungao, Nina, Patel, Gita, Perkins, Jonathan, Peters, Erica, Phillips, Rachael, Pickup, Lorinda, Piper, Jo, Plested, Emma, Presland, Laura, Qureshi, Ehsaan, Qureshi, Ehsaan, Radford, Helen, Raj, Sreena, Rampling, Tommy, Rampling, Tommy, Ramsay, Mary, Ramsay, Mary, Rashid-Gardner, Zalina, Rawlins, Todd, Read, Robert C, Read, Robert C, Regan, Karen, Regan, Karen, Renals, Valerie, Ricamara, Marivic, Richmond, Leah, Riordan, Andrew, Robinson, Hannah, Roche, Siobhan, Rogers, Chris, Romani, Rossana, Ronan, Nicholas, Roy, Subarna, Russell, Amy Ross, Sabine, Charlette, Saich, Stephen, Saich, Stephen, Sakagami, Yukari, Santos, Filipa Dos, Saralaya, Dinesh, Saralaya, Dinesh, Savage, Mary, Seath, Ingrid, Seaton, Andrew, Seenan, John Paul, Serafimova, Teona, Shaik, Imam, Shamtally, Djamila, Sharma, Rajni, Sharma, Sunil, Sharma, Sunil, Shenoy, Anil, Sheridan, Ray, Sheridan, Ray, Silva, Carla Ferreira Da, Singh, Michael, Singh, Stephen, Smith, Catherine, Snape, Matthew D, Snape, Matthew D, Snashall, Emma, Soussi, Najwa, Spence, Niamh, Spencer, Joanne, Stackpoole, Michael, Starinskij, Igor, Stewart, Anna, Stokes, Matthew, Stone, Megan, Storton, Kim, Sturdy, Ann, Suggitt, Debbie, Summerton, Eloise, Tandy, Bridget, Tasker, Suzanne, Thomas, Steve, Thomson, Emma C, Thomson, Emma C, Thorp, Helen, Thorpe, Jeanette, Todd, Shirley, Todd, Shirley, Trinham, Charlotte, Tulloch, Hayley, Tunstall, Simon, Turnbull, Iain, Turner, Nicola, Twelves, Chris, Twelves, Chris, Underwood, Karen, Ustianowski, Andrew, Vail, Denny, Vamplew, Luke, Wagstaff, Lynda, Warren, Sarah, Watson, Tara, Weighell, Rowena, Welham, Benjamin, Welsenes, Donald van, Wenn, Victoria, Westwell, Fran, Whitbred, Tim, White, Rachel, Whittington, Ashley, Whittley, Sarah, Wilkins, Suzanne, Wiselka, Martin, Wixted, Donna, Woodyatt, Wiesia, Yim, Yee Ting Nicole   +363 more
core   +4 more sources

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules:exploratory analyses of Com-COV, a randomised control trial [PDF]

, 2022
BACKGROUND: Priming COVID-19 vaccine schedules have been deployed at variable intervals globally, which might influence immune persistence and the relative importance of third-dose booster programmes. Here, we report exploratory analyses from the Com-COV

core   +6 more sources

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2

Vaccines, 2022
Emerging numbers of SARS-CoV-2 infections are currently combated with a third vaccination. Considering the different vaccination regimens used for the first two vaccine doses, we addressed whether the previous vaccination influences the immune response to the booster. Participants for this prospective study were recruited from among healthcare workers.
Rieke Reiter, Pia Von Blanckenburg, Reinier Mutters, Julia Thiemer, Reinhard Geßner, Ulf Seifart   +5 more
openaire   +4 more sources

Neutralizing Activity of BNT162b2-Elicited Serum

New England Journal of Medicine, 2021
Variant SARS-CoV-2 and BNT162b2 Vaccine How well do serum samples obtained from persons injected with the BNT162b2 vaccine neutralize the P.1, B.1.1.7, and B.1.135 lineages of SARS-CoV-2, first ide...
Yang Liu, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R. Fontes-Garfias, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Scott C. Weaver, Alexander Muik, Ugur Sahin, Kathrin U. Jansen, Xuping Xie, Philip R. Dormitzer, Pei-Yong Shi   +17 more
openaire   +2 more sources

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers

Vaccines, 2023
Assessing immune responses post-SARS-CoV-2 vaccination is crucial for optimizing vaccine strategies. This prospective study aims to evaluate immune responses and breakthrough infection in 235 infection-naïve healthcare workers up to 13–15 months after initial vaccination in two vaccine groups (108 BNT/BNT/BNT and 127 ChAd/ChAd/BNT).
Geon Young Ko, Jihyun Lee, Hyunjoo Bae, Ji Hyeong Ryu, Hye-Sun Park, Hyunhye Kang, Jin Jung, Ae-Ran Choi, Raeseok Lee, Dong-Gun Lee, Eun-Jee Oh   +10 more
openaire   +3 more sources

Immunogenicity and efficacy of          heterologous ChAdOx1–BNT162b2 vaccination [PDF]

Nature, 2021
Abstract Following severe adverse reactions in patients vaccinated with the AstraZeneca ChadOx1 (Chad) vaccine, European health authorities have recommended that patients under the age of 55 who received one dose of Chad vaccine receive a second dose of Pfizer BNT162b2 (BNT) vaccine as a booster.
Bruno Pozzetto, Vincent Legros, Sophia Djebali, Véronique Barateau, Nicolas Guibert, Marine Villard, Loïc Peyrot, Omran Allatif, Jean-Baptiste Fassier, Amélie Massardier-Pilonchéry, Karen Brengel-Pesce, Melyssa Yaugel-Novoa, Solène Denolly, Bertrand Boson, Thomas Bourlet, Antonin Bal, Martine Valette, Thibault Andrieu, Bruno Lina, Kahina Saker, Christelle Compagnon, Bouchra Mokdad, Constance d’Aubarede, Virginie Pitiot, Vanessa Escuret, Florence Morfin, Mary-Anne Trabaud, Margaux Prieux, Valérie Dubois, Laurence Josset, Soizic Daniel, François-Loïc Cosset, Stéphane Paul, Thierry Defrance, Jacqueline Marvel, Thierry Walzer, Sophie Trouillet-Assant   +36 more
openaire   +5 more sources

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 : a multicentre, randomised, double-blind, non-inferiority phase IIb trial [PDF]

, 2023
A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study dose-escalation trial.
Alvarez-Mon, Melchor, Anagua, Jesse Omar, Arana-Arri, Eunate, Arribas, Jose R., Bailón, Lucía, Barreiro, Antonio, Benet, Susana, Blanch-Lombarte, Oscar, Blanco, Julià, Borobia, Alberto M., Cañete, Manuel, Clotet Sala, Bonaventura, Comes, Aida Corpes, Compán, Salvador Oña, Corominas, Júlia, de la Villa Martínez, Sofía, Esteban, Ignasi, Fernández, Sara Rodríguez, Ferrer, Laura, Forner Giner, Maria José, Gallemí, Marçal, García, Patricia Muñoz, Garriga, Carme, González-González, Luis, Güell, Irina, Imaz-Ayo, Natale, Izquierdo Useros, Nuria, Jiménez, María del Mar Vázquez, Lucas, Rafael Ortí, Madrenas, Laia, Martí-Lluch, Ruth, Martínez Gómez, Xavier, McSkimming, Paula, Meijide, Susana, Moltó, José, Moros, Alexandra, Nava, Jocelyn, Navarro-Pérez, Jorge, Núñez-Costa, Xavier, Parada, Javier Queiruga, Pastor-Quiñones, Carmen, Plana, Montserrat, Pradenas, Edwards, Prado, Julia G., Prat, Teresa, Prenafeta, Antoni, Pérez-Caballero, Raúl, Ramos, Rafel, Raïch-Regué, Dàlia, Romero, Susana Otero, Sans-Pola, Carla, Soriano, A, Taleb, Rachel Abu, Torroella, Èlia, Trinité, Benjamin, Troncoso, Daniel, Universitat Autònoma de Barcelona   +56 more
core   +1 more source